Logo

Course

Best of ACTHIV® 2026: Pharmacokinetic Frenemies - Managing Modern Antiretroviral Drug Interactions

Details

Published Date: 09/15/2026

Expiration Date: 09/15/2027

CE Credit: CME: 0.5CNE: 0.5CPE: 0.5

Description

Selected by attendees and the program planning committee as one of the high-impact sessions of the ACTHIV® 2026 conference for the interprofessional HIV care team, this activity equips learners with practical strategies to identify and manage clinically significant drug-drug interactions involving modern oral and long-acting injectable antiretroviral regimens by understanding the underlying pharmacokinetic and pharmacodynamic mechanisms and applying evidence-based approaches to optimize patient care.

Presenter(s)

Neha Sheth Pandit,PharmD, AAHIVP

Neha Sheth Pandit, PharmD, is a Professor and Vice Chair of Research and Scholarship for the University of Maryland Baltimore School of Pharmacy. She completed her PGY1 at New York-Presbyterian Hospital and her HIV Specialty Residency at University at Buffalo. Since the completion of her training, she has served as the clinical pharmacist at the University of Maryland Medical Center’s HIV outpatient, THRIVE Program. Over the years she has served on the board of a federally-qualified health center, the Advisory Board for the Maryland AIDS Drug Assistance Program, the Drug Utilization Review Board for Maryland Medicaid, various committees for the HIV PRN American College of Clinical Pharmacy (ACCP), Society of Infectious Diseases Pharmacists (SIDP), and the American Academy of HIV Medicine (AAHIVM).

Learning Objectives

  • Describe pharmacokinetic and pharmacodynamic drug interaction mechanisms involving modern antiretroviral regimens.
  • Identify common and clinically significant drug-drug interactions affecting modern oral and long-acting injectable antiretroviral regimens.
  • Apply evidence-based strategies to mitigate or prevent adverse interactions in patients on modern antiretroviral regimens.

Continuing Education Credit Information